Abstract
<h3>Aims</h3> Intraductal papillary mucinous neoplasms (IPMNs) may be precursor lesions of pancreatic cancer. The path towards malignancy is associated with mutations in tumour suppressor—and oncogenes that may serve as biomarkers during diagnostic investigation. A novel micro forceps has made it possible to obtain biopsies from the cyst wall for analysis by next generation sequencing (NGS), providing an opportunity for early detection and intervention. However, the impact of spatial tumour heterogeneity on the representability of the biopsies has not been determined. The primary aim is to characterise the impact of molecular heterogeneity of the luminal cyst wall on tissue sampling strategies with small biopsies. <h3>Methods</h3> We performed NGS and immunohistochemical phenotyping on 18 resected IPMNs with varying degrees of dysplasia and for a subset, concomitant carcinoma, using a commercially available NGS-panel of 51 oncogenes. We simulated endoscopic biopsies by performing punch biopsies (PBs) of the cyst wall from resected specimens. <h3>Results</h3> In total, 127 NGS analyses were performed. Concomitant <i>KRAS</i> and <i>GNAS</i> was a common feature of the IPMNs. Mutations in <i>KRAS</i> and <i>GNAS</i> were associated with low-grade dysplasia whereas alterations in <i>TP53, SMAD4</i>, <i>CDKN2A</i> and <i>PIK3CA</i> were associated with high-grade dysplasia and/or carcinoma. The mutational analysis of the PBs from the cyst wall was compared with the whole lesion. No difference was detected between PBs and whole lesions when the cumulated mutational profile in increasing order of randomly performed PBs was compared. <h3>Conclusions</h3> Small IPMN biopsies from the cyst wall are adequate to yield a molecular diagnosis.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call